• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleOct. 30, 2025, 1:15 PM EDT / Updated Oct. 31, 2025, 12:05 PM EDTBy Jane C. TimmOhio Republican and Democratic lawmakers unanimously approved a new congressional map that would give a slight, but not overwhelming, boost to the GOP ahead of next year’s midterm elections.At a meeting Friday morning, members of the state’s bipartisan redistricting commission approved the proposed map, which was released on Thursday as part of an unexpected deal. The map shifted two Democratic-held districts to the right and one to the left while also maintaining 10 districts that favor Republicans and two that are Democratic strongholds. Punchbowl News was first to report details of the deal.Suzan DelBene, the chair of the Democratic Congressional Campaign Committee, said “this is not a fair map for Ohio voters,” but praised Democratic legislators for “negotiating to prevent an even more egregious gerrymander.”“This compromise keeps us on the path to taking back the House Majority and we’ll continue to win across Ohio because voters know it’s House Democrats who are fighting for them,” DelBene said in a statement. The new map came as a surprise to many observers. Democrats largely expected the constitutionally mandated redistricting commission to reach a stalemate, as it did in 2021. If the commission failed to settle on a new map ahead of the 2026 elections, responsibility for setting congressional boundaries would have fallen back to the Republican-controlled Legislature, which could have drawn an aggressively gerrymandered map. If that happened, Democrats had threatened to pursue a statewide referendum that could have resulted in voters blocking the map from going into effect.The map won’t be subject to a referendum, while Democrats avoided the worst-case scenario map. In negotiations, a source familiar with the negotiations said, Republicans showed Democrats a map that had the GOP controlling 13 of the state’s 15 districts. A voter referendum on such a map would have required Democrats to gather nearly 250,000 signatures in just 90 days, a difficult feat under any scenario, let alone during the holidays and Ohio’s winter months. Lawmakers on the redistricting commission faced some protests at Friday’s meeting. “Shame, shame on you all,” said members of the public who attended the meeting to offer comment. “You sold us out!”Ohio is represented in Congress by 10 Republicans and five Democrats. Democratic Reps. Greg Landsman and Marcy Kaptur would face more competitive districts under the new map, while Rep. Emilia Sykes’ district would become slightly more Democratic.After the bipartisan commission approved the map Friday, Kaptur and Sykes said they would run for re-election under the news district lines.”Let the Columbus politicians make their self-serving maps and play musical chairs, I will fight on for the people and ask the voters for their support next year,” Kaptur said in a post on X.Under the current lines, the Cook Political Report with Amy Walter rated Kaptur’s and Sykes’ seats as “toss ups” and Landman’s as “likely Democratic.”The emergence of Ohio’s new map proposal comes amid an unusually aggressive mid-decade redistricting cycle, kicked off by President Donald Trump, who has asked Republican-led states to draw new maps in an effort to shore up the party’s narrow U.S. House majority. Texas, Missouri and North Carolina have all drawn maps boosting Republicans, while California Democrats are asking voters to approve new district lines next week. Virginia Democrats took the first major step this week towards modifying their redistricting commission to allow them to redraw their state’s map next year, while Indiana GOP lawmakers are expected to soon consider a redistricting effort. Other states, including Louisiana, await a Supreme Court ruling they hope could open the door to redrawing their congressional maps next year, too.Jane C. TimmJane C. Timm is a senior reporter for NBC News.

admin - Latest News - October 31, 2025
admin
12 views 16 secs 0 Comments




Ohio Republican and Democratic lawmakers are set to agree to a deal on a new congressional map that would give a slight, but not overwhelming, boost to the GOP.



Source link

TAGS:
PREVIOUS
Freddy Kruger actor receives Walk of Fame star
NEXT
Judge orders SNAP benefits to be paid
Related Post
November 4, 2025
Nov. 4, 2025, 4:10 PM ESTBy Berkeley Lovelace Jr.The Trump administration is expected to announce, as early as this week, a deal with drugmakers Eli Lilly and Novo Nordisk to lower the price of their weight loss drugs in exchange for limited Medicare coverage, according to two people familiar with the plan. The deal would reduce the cost of the lowest doses of the blockbuster GLP-1 medications — Lilly’s Zepbound and Novo Nordisk’s Wegovy — to $149 a month, the people said. In return, Medicare would cover the drugs for some Medicare beneficiaries. It’s not yet clear whether the $149 price would apply broadly across private and public insurance, or only for people paying in cash. It wasn’t immediately clear which Medicare patients would qualify for coverage. The details of the plan could still change. The people confirmed the possible deal on the condition of anonymity because they were not authorized to speak publicly. The news was first reported by Endpoint News. The Washington Post reported the deal could be announced as early as Thursday. White House spokesperson Kush Desai said in a statement, “Discussion about deals that have not been officially announced by the Administration should be regarded as speculation.” In emailed statements, spokespeople for Lilly and Novo Nordisk confirmed they are in discussions with the Trump administration, but offered no details on any potential deal.If finalized, it would be the most significant agreement to emerge from President Donald Trump’s efforts to lower prescription drug prices to align more closely with other developed nations — also known as his “most favored nation” drug pricing push. Trump revived the initiative through an executive order in May after unsuccessfully pursuing it during his first term. The administration has also reached agreements with Pfizer and AstraZeneca to lower costs for some prescription drugs under Medicaid.In October, Trump said the administration was close to a deal to lower the cost of weight loss drugs.”Instead of $1,300, you’ll be paying about $150,” he said from the White House. Zepbound and Wegovy currently carry list prices above $1,000 a month — although both companies have rolled out lower cost options for people paying in cash amid intense public scrutiny over the high cost of the drugs. Costco recently announced that it would sell Wegovy and its diabetes drug Ozempic for $499 to people without insurance; Lilly announced a similar deal with Walmart for Zepbound. Medicare currently covers Wegovy for patients at risk of heart disease, as well as Zepbound for sleep apnea — but not for weight loss alone. Ozempic, which has the same active ingredient as Wegovy, is covered for diabetes.The Biden administration proposed expanding coverage of GLP-1 drugs through Medicare and Medicaid but the Trump administration later rejected the plan. Ozempic and Wegovy are also included in the next round of Medicare drug price negotiations under the Inflation Reduction Act, which former President Joe Biden signed into law in 2022. The Trump administration was expected to finalize new prices for 15 drugs — including the GLP-1s — by Nov. 1. Trump officials have signaled less enthusiasm for the negotiations, instead focusing on executive orders and voluntary pricing agreements with drugmakers. The administration is expected to unveil the new prices by Nov. 30. Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
September 30, 2025
Illinois Gov. Pritzker slams Trump over ICE raids
November 26, 2025
Georgia election case against Trump dismissed
September 30, 2025
Trump announces drug pricing deal with Pfizer
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved